作者: Y. M. Rustum , L. Liu , Z. Zhang
DOI: 10.1007/978-1-4684-5607-3_4
关键词:
摘要: During the last 30 years, 5-fluorouracil (FUra)* has been drug of choice for treatment patients with adenocarcinoma colon. This agent is also active against breast carcinoma and significant activity in head neck. In all cases, but especially colon carcinoma, response rate low duration relatively short, on order 6 to 9 months.